AVNET INC Debt Disclosure
7. Debt
Short-term debt consists of the following (carrying balances in thousands):
June 28, | June 29, | June 28, | June 29, | ||||||||||
2025 |
| 2024 |
| 2025 |
| 2024 | |||||||
Interest Rate | Carrying Balance |
| |||||||||||
Revolving credit facilities: | |||||||||||||
Accounts receivable securitization program | — | 6.19 | % | $ | — | $ | 415,100 | ||||||
Other short-term debt | 5.17 | % | 5.43 | % | 87,284 | 77,611 | |||||||
Short-term debt | $ | 87,284 | $ | 492,711 | |||||||||
Other short-term debt consists of various committed and uncommitted lines of credit and other forms of bank debt with financial institutions utilized primarily to support the ongoing working capital requirements of the Company, including its foreign operations.
Long-term debt consists of the following (carrying balances in thousands):
June 28, | June 29, | June 28, | June 29, | ||||||||||
2025 |
| 2024 |
| 2025 |
| 2024 | |||||||
Interest Rate | Carrying Balance |
| |||||||||||
Revolving credit facilities: | |||||||||||||
Accounts receivable securitization program (due December 2026) | 5.18 | % | — | $ | 500,000 | $ | — | ||||||
Credit Facility (due January 2030) | 5.46 | % | 5.05 | % | 411,586 | 745,480 | |||||||
Other long-term debt | 4.74 | % | 4.74 | % | 21,975 | 22,748 | |||||||
Public notes due: | |||||||||||||
April 2026 (1) | 4.63 | % | 4.63 | % | 550,000 | 550,000 | |||||||
March 2028 | 6.25 | % | 6.25 | % |
| 500,000 |
| 500,000 | |||||
May 2031 | 3.00 | % | 3.00 | % | 300,000 | 300,000 | |||||||
June 2032 | 5.50 | % | 5.50 | % | 300,000 | 300,000 | |||||||
Long-term debt before discount and debt issuance costs |
| 2,583,561 |
| 2,418,228 | |||||||||
Discount and debt issuance costs – unamortized |
| (8,832) |
| (11,599) | |||||||||
Long-term debt | $ | 2,574,729 | $ | 2,406,629 | |||||||||
| (1) | As of June 28, 2025, the Company classified its $550 million of 4.63% Notes due April 2026 as long-term debt based on its ability and intent to refinance these notes on a long-term basis. |
In December 2024, the Company amended and extended for two years its trade accounts receivable securitization program (the “Securitization Program”) in the United States with a group of financial institutions which is due in December 2026. The Securitization Program allows the Company to transfer, on an ongoing revolving basis, an undivided interest in a designated pool of trade accounts receivable, to provide security or collateral for borrowings of up to $500.0 million. The Securitization Program does not qualify for off balance sheet accounting treatment and any borrowings under the Securitization Program are recorded as debt in the consolidated balance sheets. Under the Securitization Program, the Company legally sells and isolates certain U.S. trade accounts receivable into a wholly owned and consolidated bankruptcy remote special purpose entity. Such receivables, which are recorded within “Receivables” in the consolidated balance sheets, totaled $813.9 million and $1.05 billion at June 28, 2025, and June 29, 2024, respectively. The Securitization Program contains certain covenants relating to the quality of the receivables sold.
There were $500.0 million and $415.1 million borrowings outstanding under the Securitization Program as of June 28, 2025, and as of June 29, 2024, respectively.
In January 2025, the Company amended and extended its five-year $1.50 billion revolving credit facility (the “Credit Facility”) with a syndicate of banks, which expires in January 2030. It consists of revolving credit facilities and the issuance of up to $200.0 million of letters of credit and up to $300.0 million of loans in certain approved currencies. Under the Credit Facility, the Company may select from various interest rate options, currencies, and maturities. The Credit Facility contains certain covenants including various limitations on debt incurrence, share repurchases, dividends, investments, and capital expenditures. The Credit Facility also includes a financial covenant requiring the Company to maintain a minimum leverage ratio, which the Company was in compliance with as of June 28, 2025. At June 28, 2025, and June 29, 2024, there were $0.9 million in letters of credit issued under the Credit Facility.
Aggregate debt maturities for the next five fiscal years and thereafter are as follows (in thousands):
2026 |
| $ | 637,284 | |
2027 |
| 500,000 | ||
2028 |
| 500,000 | ||
2029 |
| — | ||
2030 |
| 411,586 | ||
Thereafter |
| 621,975 | ||
Subtotal |
| 2,670,845 | ||
Discount and debt issuance costs – unamortized |
| (8,832) | ||
Total debt | $ | 2,662,013 |
At June 28, 2025, the carrying value and fair value of the Company’s total debt was $2.66 billion and $2.65 billion, respectively. At June 29, 2024, the carrying value and fair value of the Company’s total debt was $2.90 billion and $2.85 billion, respectively. Fair value for the public notes was estimated based upon quoted market prices (Level 1) and, for other forms of debt, fair value approximates carrying value due to the market based variable nature of the interest rates on those debt facilities (Level 2).
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Aug 15, 2025 | Showing above |
| 2024 | Aug 14, 2024 | |
| 2023 | Aug 18, 2023 | |
| 2022 | Aug 12, 2022 | |
| 2021 | Aug 13, 2021 | |
| 2020 | Aug 14, 2020 | |
| 2019 | Aug 15, 2019 | |
| 2018 | Aug 17, 2018 | |
| 2017 | Aug 17, 2017 | |
| 2016 | Aug 12, 2016 | |
About Debt Disclosures
Debt disclosures detail a company's borrowing structure — the types of instruments, interest rates, maturity schedule, and covenant restrictions that define its financial obligations and flexibility. This section is essential for assessing refinancing risk, interest rate exposure, and the margin of safety against financial distress.
Key signals: the maturity schedule reveals concentration risk — large maturities within 1-2 years during tight credit markets can force dilutive refinancing or asset sales. Compare the fair value of debt against carrying amount to gauge whether the market views the company's credit risk differently than the balance sheet suggests. Watch covenant compliance disclosures for tightening cushions, especially leverage and interest coverage ratios. Variable-rate debt exposure quantifies sensitivity to interest rate changes. Secured versus unsecured mix affects recovery rates and future borrowing capacity. Compare net debt-to-EBITDA against industry peers and covenant limits to assess financial health.